Cytoplasmic poly(adenosine diphosphate-ribose) polymerase expression is predictive and prognostic in patients with breast cancer treated with neoadjuvant chemotherapy.

von Minckwitz, Gunter

Cytoplasmic poly(adenosine diphosphate-ribose) polymerase expression is predictive and prognostic in patients with breast cancer treated with neoadjuvant chemotherapy. [electronic resource] - Journal of clinical oncology : official journal of the American Society of Clinical Oncology Jun 2011 - 2150-7 p. digital

Publication Type: Journal Article

1527-7755

10.1200/JCO.2010.31.9079 doi


Adenocarcinoma--drug therapy
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Biomarkers, Tumor--analysis
Breast Neoplasms--drug therapy
Clinical Trials, Phase II as Topic
Clinical Trials, Phase III as Topic
Cyclophosphamide--administration & dosage
Cytoplasm--enzymology
Disease-Free Survival
Docetaxel
Doxorubicin--administration & dosage
ErbB Receptors--biosynthesis
Female
Humans
Immunohistochemistry
Kaplan-Meier Estimate
Multicenter Studies as Topic
Neoadjuvant Therapy
Poly(ADP-ribose) Polymerases--metabolism
Prognosis
Randomized Controlled Trials as Topic
Receptors, Estrogen--biosynthesis
Receptors, Progesterone--biosynthesis
Taxoids--administration & dosage
Treatment Outcome